Coronavirus: The global race to patent a remedy

As a lethal coronavirus triggers a humanitarian crisis in the world’s most populous nation, who owns the rights to a potential cure?

The Bay Area’s pharmaceutical powerhouse Gilead Sciences is first in line for a Chinese patent for its drug called Remdesivir, which shows promise against the broad family of coronaviruses.

https://www.eastbaytimes.com/2020/02/13/coronavirus-the-global-race-to-patent-a-remedy/